Literature DB >> 18797445

Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetes.

Pierre Souraty1, Cynthia C Nast, Rajnish Mehrotra, Lilly Barba, John Martina, Sharon G Adler.   

Abstract

BACKGROUND: A 56-year-old man with previously treated hepatitis C presented to a nephrology clinic with hypertension, proteinuria and declining renal function. His medical history included previous smoking, prior hip replacements with prolonged osteomyelitis, and left renal artery stenosis. Diabetes mellitus was ruled out by a 2 h oral glucose tolerance test and two glycated hemoglobin (HbA 1c) measurements. A renal biopsy showed evidence of nodular glomerulosclerosis. INVESTIGATIONS: Physical examination, renal biopsy, and urine and blood analyses including an oral glucose tolerance test. DIAGNOSIS: Nodular glomerulosclerosis and metabolic syndrome. MANAGEMENT: Patients with metabolic syndrome should be screened for evidence of renal injury since clinical and histological nodular glomerulosclerosis identical to diabetic nephropathy can occur in this setting. Early diagnosis and treatment of albuminuria could alter the course of disease progression.

Entities:  

Mesh:

Year:  2008        PMID: 18797445     DOI: 10.1038/ncpneph0946

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  7 in total

1.  Overstated conclusions and overstretched diagnosis?

Authors:  Malvinder S Parmar
Journal:  Nat Clin Pract Nephrol       Date:  2009-02

2.  Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases.

Authors:  Jun Wu; Shengqiang Yu; Vickram Tejwani; Michael Mao; Angela K Muriithi; Chaoyang Ye; Xuezhi Zhao; Hongchen Gu; Changlin Mei; Qi Qian
Journal:  Clin Exp Nephrol       Date:  2014-01-10       Impact factor: 2.801

3.  A case of idiopathic nodular glomerulosclerosis with fibrin caps.

Authors:  Chiharu Kinoshita; Yoshimoto Inoue; Yoko Kanda; Chiaki Kanda
Journal:  Clin Exp Nephrol       Date:  2011-08-17       Impact factor: 2.801

4.  Drug of choice in the management of hypertension in diabetes and diabetic nephropathy: angiotensin-converting enzyme inhibitors.

Authors:  Eberhard Ritz
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04       Impact factor: 3.738

5.  Clinical, histopathologic and molecular features of idiopathic and diabetic nodular mesangial sclerosis in humans.

Authors:  Michael T Eadon; Sam Lampe; Mirza M Baig; Kimberly S Collins; Ricardo Melo Ferreira; Henry Mang; Ying-Hua Cheng; Daria Barwinska; Tarek M El-Achkar; Tae-Hwi Schwantes-An; Seth Winfree; Constance J Temm; Michael J Ferkowicz; Kenneth W Dunn; Katherine J Kelly; Timothy A Sutton; Sharon M Moe; Ranjani N Moorthi; Carrie L Phillips; Pierre C Dagher
Journal:  Nephrol Dial Transplant       Date:  2021-12-31       Impact factor: 5.992

Review 6.  Limitations and future treatment options in type 2 diabetes with renal impairment.

Authors:  Eberhard Ritz
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

7.  Diabetic nephropathy - Epidemiology in Asia and the current state of treatment.

Authors:  E Ritz; X Zeng
Journal:  Indian J Nephrol       Date:  2011-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.